Are you Dr. Kutok?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
# Brigham
Boston, MA 02115Phone+1 617-732-5714
Summary
- Dr. Jeffery Kutok, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is an Associate Professor of Pathology at Brigham and Women's Hospital.
Education & Training
Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1995 - 1999
Stony Brook University Health Sciences Center School of MedicineClass of 1995- Brigham and Women's HospitalFellowship, Hematopathology
Certifications & Licensure
MA State Medical License 1999 - 2018- American Board of Pathology Anatomic Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- 601 citationsOvercoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cellsOlivier De Henau, Matthew Rausch, David W. Winkler, Luis Felipe Campesato, Cailian Liu
Nature. 2016-11-17 - 806 citationsPI3Kγ is a molecular switch that controls immune suppressionMegan M. Kaneda, Karen Messer, Natacha Ralainirina, Hongying Li, Christopher J. Leem
Nature. 2016-11-17 - 138 citationsAutocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemiaAlex Kentsis, Casie Reed, Kim L. Rice, Takaomi Sanda, Scott J. Rodig
Nature Medicine. 2012-07-01
Press Mentions
Epizyme Presents Preclinical Data and Phase 1/1b Trial Design on the Company’s SETD2 Inhibitor, EZM0414, at the 2021 ASH Annual MeetingDecember 11th, 2021
Epizyme Hires Kutok as CSO to Find New Uses for TazverikMarch 20th, 2020- Chutes & Ladders—Bristol Myers Squibb Appoints Mily to Strategy LeadMarch 20th, 2020
- Join now to see all
Grant Support
- Tissue Banking And Molecular AssessmentNational Cancer Institute2006–2010
